Novo Nordisk Bets on Oral Pill and CagriSema to Reclaim Obesity Leadership After 60% Sell-Off
Novo Nordisk rallies on oral Wegovy’s 21.6% weight loss, bests Lilly; CagriSema submitted for US approval. Stock up…
Browsing Tag